Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Globalisation creates unique regulatory challenges, says CDRH director

This article was originally published in RAJ Devices

Executive Summary

Though the US Food and Drug Administration is increasing the number of foreign inspections it carries out abroad, this is not the only answer to ensuring the safety of imported medical devices, says the director of the agency’s Center for Devices and Radiological Health. During a presentation at AdvaMed’s 2009 International Medical Device Industry Compliance, Regulatory and Intellectual Property Conference held in Rome, Italy, from 25-27 May, Daniel Schultz said that the globalisation of the medtech market had created “unique regulatory challenges” and, thus, the agency needed to find innovative ways to deal with them.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts